| Financial Year |
March 31 2023 |
| Monetary Funds |
615,140,460.52 |
| Held-for-trading Financial Assets |
79,466.59 |
| Notes Receivable |
570,493.00 |
| Accounts Receivable |
174,109,108.04 |
| Advances to Suppliers |
2,213,828.68 |
| Other Receivables |
15,971,858.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,389,004.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
108,451,765.88 |
| Other Current Assets |
7,011,839.70 |
| Total Current Assets |
1,108,666,119.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,306,576.71 |
| Fixed Assetes |
146,944,533.54 |
| Under-construction Projects |
4,922,527.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,719,919.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,570,604.93 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
223,209,475.49 |
| Total Assets |
1,331,875,594.84 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
68,779,942.60 |
| Accounts Payable |
159,982,909.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,192,838.64 |
| Taxes Payable |
3,431,468.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,135,848.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,444,774.19 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
558,916,447.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,357,709.49 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,308,762.05 |
| Total Liabilities |
575,225,209.06 |
| Paid-In Capital(Or Share Stock) |
266,786,667.00 |
| Capital Surplus |
158,509,614.37 |
| Surplus Reserve |
54,287,797.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
270,466,400.37 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
756,650,385.78 |
| Owner's Equity（Stockholder's Equity） |
756,650,385.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,331,875,594.84 |
